New HCPCS Codes Effective for Certain Drugs and Biologicals
Q2045 Injection, human fibrinogen concentrate, 1 mg
Q2046 Injection, aflibercept, 1 mg
Q2047 Injection, Peginesatide, 0.1 MG (for ESRD on Dialysis)
Q2048 Injection, doxorubicin hydrochloride, liposomal, doxil, 10 mg
Q2049 Injection, doxorubicin hydrochloride, liposomal, imported lipodox, 10 mg
Q2034 Influenza virus vaccine, split virus, for intramuscular use (Agriflu)
Level II HCPCS code J1680 (Injection, human fibrinogen concentrate, 100 mg) will be replaced with HCPCS code Q2045 effective July 1, 2012. The status indicator for HCPCS code J1680 will change to E, “Not Payable by Medicare”, effective July 1, 2012.
Level II HCPCS code C9291 (Injection, aflibercept, 2 mg vial) will be deleted June 30, 2012, and replaced with HCPCS code Q2046 effective July 1, 2012.
Level II HCPCS code J9001 (Injection, doxorubicin hydrochloride, all lipid formulations, 10 mg) will be replaced with HCPCS code Q2048 effective July 1, 2012. The status indicator for HCPCS code J9001 will change to E, “Not Payable by Medicare”, effective July 1, 2012.
